USPTO serial 79289697
MOGRIFY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 27, 2021
- Examiner
- MASON, JARED MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with MOGRIFY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,544*
Plus Government fees of $1,950
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebecca Liebowitz
Rebecca Liebowitz Venable LLPP.O. Box 34385Washington, DC 20043-9998UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for research purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use | ACTIVE | — |
| 005 | Medical and veterinary preparations for therapeutic purposes, namely pharmaceutical and biopharmaceutical preparations for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; pharmaceutical and biopharmaceutical preparations for cell therapy; pharmaceutical and biopharmaceutical preparations for modifying human or animal cells for medical or therapeutic purposes; biological, chemical and biochemical reagents for medical use | ACTIVE | — |
| 009 | Downloadable bioinformatics software for genomic data analysis; downloadable computer software platforms for genomic data analysis in the fields of ophthalmology, haematology, immunology, neurology, respiratory diseases, metabolic conditions, genetic conditions, oncology, immuno-oncology, infectious diseases and cardiovascular diseases; scientific apparatus for measuring and analysing scientific study data in the nature of apparatus for recording, transmission or reproduction of data including video, audio, images and text; data analysis apparatus in the nature of data processing equipment and computers and downloadable operating computer software sold as a unit; downloadable scientific data analysis software | ACTIVE | — |
| 040 | Treatment and processing of biological materials, namely cells, stem cells, induced pluripotent stem cells; custom manufacture of therapeutic drugs, namely custom manufacture of transcription factors, cells and cell therapies, gene therapies ; information, advisory and consultancy services in relation to all of the aforesaid services | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the fields of ophthalmology, haematology, immunology, neurology, respiratory diseases, metabolic conditions, genetic conditions, oncology, immuno-oncology, infectious diseases and cardiovascular diseases; industrial research services in the field of cell therapies and gene therapies; medical and veterinary research services in the nature of the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; design and development of new products for others; scientific laboratory services; software as a service (SaaS) services featuring software for use in genomic data analysis; platform as a service (Paas) services that feature a computer bioinformatics platform for use in manufacturing therapeutics; providing a bioinformatics platform for identifying transcription factors to turn one cell type into another cell type; advisory and consultancy relating to all the aforesaid services | ACTIVE | — |
| 044 | Medical services; veterinary services; medical services for the treatment of conditions of the human or animal body; medical services in the nature of manipulation of human and animal cells for therapeutic purposes; providing advice and consultancy in the field of medical and veterinary therapies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Mogrify Limited
- Other trademarks owned by Mogrify Limited
- Other trademarks owned by Mogrify Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MOGRIFY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 27, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 4, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 13, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 13, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 27, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 27, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 11, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 11, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 11, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 21, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 21, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 21, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 2, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 2, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 2, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 2, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 2, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 25, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 25, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 25, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 4, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 4, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 4, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 4, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 11, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 11, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 12, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 11, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 10, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 25, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 21, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 16, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |